Johnson & Johnson (JNJ)
$62.31
0.37 (+0.60%)
| CAPS Rating |
|
|---|---|
| Open | $61.82 |
| Previous Close | $61.94 |
| Daily Range | $61.72 - $62.62 |
| 52-Week Range | $46.25 - $62.74 |
| Market Cap | $171.92B |
| P/E Ratio | 13.51 |
| Dividend (Yield) | 1.96 (3.10%) |
| Volume | 16,299,234 |
| Average Daily Volume | 13,103,000 |
JNJ
VS S&P 500 (SPY)
How do you think JNJ will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
JNJ Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
JNJ News and Commentary
- The Highest Possible Returns. Period. – The Motley Fool
- MARKET SNAPSHOT: Investors May Turn Defensive As Fizz Leaves Stocks – SmartMoney
- Who's Paying for Health-Care Reform? – The Motley Fool
- An Open Letter to the Federal Reserve – The Motley Fool
- Now Is the Time to Buy Risk – The Motley Fool
- Fusion IP Signs Licensing Deal With Orthopedic Firm – SmartMoney
- US Cosmetic Medical Market Faces New Challenge In Senate Bill – SmartMoney
- US Senate Bill Includes Lower $2 Billion Medical Device Tax – SmartMoney
- The Only Asset Worth Owning Today – The Motley Fool
- 5-Star Stocks Poised to Pop: Female Health – The Motley Fool
- Why You Can't Afford to Miss These Stocks – The Motley Fool
- The Type of Stock You Should Never, Ever Buy – The Motley Fool
- Your Heart or Your Stomach? – The Motley Fool
- Can This Stock Go Higher? – The Motley Fool
- CMED Earning Outlook – Blog at The Motley Fool
- 5-Star Stocks Poised to Pop: Unilever – The Motley Fool
- These Dividends Are Safe – The Motley Fool
- STOCKS ARE STILL CHEAP despite market run up – Blog at The Motley Fool
- 4-Star Stocks Poised to Pop: Alkermes – The Motley Fool
- Are You Ready to Make Real Money? – The Motley Fool
RSS Headlines
Fool UK
